Delivery Order SPE2DR25D2014-SPE2DR26FZ92E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,959.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (500 count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the agency. The product will be delivered to the company's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,501.50 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets in quantities of 500 units. This firm fixed price delivery order, issued on September 25, 2025, represents a non-competitive award under an existing contract vehicle and is scheduled for ultimate completion by September 26, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 10 mg tablets (500 count) valued at $46,580.81 under a firm fixed-price contract. This competitively awarded delivery order, with no set-aside designation, was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,329.50 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies the place of performance as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Citalopram HBR 40 mg tablets in a quantity of 500 units. This is a firm fixed-price delivery order with a ceiling value of $6,230.19 and an ultimate completion date of December 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,069.57 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count). This competitively awarded, non-set-aside contract was issued on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The firm fixed price delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Citalopram HBr 20 mg tablets (500 count) valued at $1,582.47. This firm fixed-price delivery order, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no...
- The Defense Logistics Agency (DLA) awarded a $16,222.46 delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Citalopram HBr 40 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of June 9, 2025, and performance to be executed from the vendor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Citalopram HBR 40 mg tablets (500-count units) with a ceiling value of $12,406.14. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $4,636.42 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) on December 1, 2025, with completion expected by December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ92EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (500-count units) valued at $12,744.27 under a firm fixed-price contract. The award, made on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a non-competitive delivery order executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the fulfillment location for this pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. As the prime vendor for this comprehensive global pharmaceutical support vehicle, the company supplies a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and other federal healthcare systems. The contract demonstrates the company's significant role in the federal pharmaceutical supply chain for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 12/8/25 |